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be suppressed after release of inhibiting factors stimulated by 
PUV A irradiation. 
The alternative mechanism of PUV A-induced inhibition of 
T cell function remains to be elucidated. 
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Corrected Date for the 
International Symposium 
on the Treatment of 
Psoriasis and Psoriatic Arthritis 
This international symposium had been previously scheduled for February 1979 and will now be held 
from November 18-25, 1979. Speakers include Drs. T . J . Ryan. F. Sagher. N. Hjorth. and H. Maibach. 
The offici.allanguage of the Symposium is English. The sessions will take place in Tel Aviv and the Dead 
Sea. Information can be obtained by writing or cabling N. D. Yahalom, 44 Ibn Gvirol. Tel Aviv, Israel. 
The meeting is sponsored by the Dermatology Department of the Hadassah Hospital. The Israeli 
Dermatologic Society. and the International Psoriasis Treatment Center. 
